Moreover, sex-associated levels of atherogenic metabolites such as the apolipoprotein B to A1 ratio (ApoB:ApoA1) are proposed to contribute to the sex-associated risk of cardiovascular disease (8). This evidence concerns the gene APOB and cardiovascular disorder.